Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
Serdal UğurluBilgesu ErgezenBugra Han EgeliOguzhan SelviHuri OzdoganPublished in: Rheumatology (Oxford, England) (2021)
In patients who were refractory to colchicine, anti-IL-1 agent anakinra was shown to be effective and safe. The effectiveness of anakinra stems from preventing attacks and increasing the quality of life.